Laserfiche WebLink
will be used in the event the first container has become contaminated. Both <br />samples are to be sent to the testing laboratory. <br />(e) Before the specimen ever leaves the individual's sight, the urine container will <br />be sealed with security tape which has been initialed by the individual. <br />(f) Specimens collected on -site will be picked up by courier and transported to the <br />laboratory for testing. A portion of the sample will be tested using the EMIT test <br />and if positive, another portion will be tested for verification using the GC/MS test. <br />(g) The remainder of the urine specimen will be maintained at the laboratory for <br />thirty (30) days following the date of the test. <br />(h) After having submitted an acceptable sample, an individual submitting for the <br />Initial Drug Screen will then be given a form stating that he/she has consented to <br />and given urine sample for drug screening and is available for employment for a <br />probationary period, pending results of the initial drug screening. This form will be <br />signed by the attending medical personnel and a supervisor of his/her employer. <br />(i) Any individual who refuses to take a drug test will not be eligible for <br />employment by any contractor at Projects covered by the M.U.S.T. Drug and <br />Alcohol Screening Program. <br />0) The results of the drug test will be posted on the individuals Report Card. If the <br />individual has tested positive or has otherwise become ineligible with the Program <br />the results of the drug test will be communicated to the contractor's designated <br />representative by the MRO, he/she will be removed from the Project immediately <br />and paid for all hours worked. The individual will not be eligible for employment <br />with any employer on Projects covered by this Program in accordance with Section <br />15 contingent on a negative drug screen. <br />(k) The individual will be provided a copy of positive test results by the MRO, if <br />requested. <br />(l) Retesting: Retesting provides the opportunity to confirm a positive test result <br />by having a GC/MS test performed on the split sample previously collected at a <br />SAMHSA (Substance Abuse and Mental Health Services Administration) certified <br />laboratory of their choice. The following procedures shall apply: <br />(1) Within five (5) work days of being notified of the positive test results, <br />such individual must submit a letter to the MUST Program Manager <br />requesting confirmation of the positive test. <br />(2) The above letter must include the name, address and telephone <br />number of the SAMHSA laboratory of their choice. Only SAMHSA <br />certified laboratories may be utilized. An individual <br />Adamo CHSP Section 10.0 <br />Drug -Free Workplace 9 February 2023 Issue <br />